Evidence for differentiation of NK1+cells into cytotoxic T cells during acute rejection of allogeneic bone marrow grafts
โ Scribed by Gunther Dennert; Christian Knobloch; Shunji Sugawara; Boris Yankelevich
- Book ID
- 104666702
- Publisher
- Springer-Verlag
- Year
- 1990
- Tongue
- English
- Weight
- 729 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0093-7711
No coin nor oath required. For personal study only.
โฆ Synopsis
The ability of lethally irradiated C57BL/6 mice to acutely reject H-2d bone marrow is due to a lymphocyte population that is NK1+, ASGM1+, CD4-, CD8-, CD3+. Transfer of spleen cells from C57BL/6 mice expressing these antigens into nonresponder 129 mice adoptively transfers the ability to reject H-2d marrow grafts. The specificity of this rejection maps to the H-2D major histocompatibility complex (MHC) region. Transplantation of high doses of H-2d marrow into C57BL/6 overrides the acute rejection mechanism leading to graft survival. During growth of the graft, a cytolytic activity develops that is due to ASGM1+, CD8+ cytolytic T lymphocytes (CTLs) with H-2Ld specificity. The possibility that the ASGM1+, CD8+ CTLs are descendents of the CD3+, NK1+, ASGM1+, CD8- cells responsible for acute rejection is investigated by adoptive cell transfer experiments. We show that beige mice that lack NK1+ cells as well as the ability to acutely reject H-2d marrow fail to generate specific CTLs after transplantation with a high dose of H-2d marrow. Transfer of highly purified NK1+ cells from B6.PL-Ly-2a/Ly-3a (Lyt-2.1) into beige mice together with H-2d marrow leads to generation of Lyt-2.1 CTLs from donor NK1+ cells. These results show that specific CTLs are generated from NK1+ cells during acute marrow graft rejection.
๐ SIMILAR VOLUMES
## CD134 (OX-40 ) is an activation-associated antigen which functions as a costimulatory receptor for CD4ุ T cells. In order to determine the expression of CD134 during immune recovery following allogeneic bone marrow transplantation (BMT), we measured its expression on T cells and T cell subsets